Tenascin-c knockdown suppresses vasculogenic mimicry of gastric cancer by inhibiting ERK-triggered EMT (vol 12, 890, 2021)

被引：0
|
作者：
Kang, Xing
Xu, En
Wang, Xingzhou
Qian, Lulu
Yang, Zhi
Yu, Heng
Wang, Chao
Ren, Chuanfu
Wang, Yizhou
Lu, Xiaofeng
Xia, Xuefeng
Guan, Wenxian
Qiao, Tong
机构：
[1] Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University,Department of General Surgery
[2] Medical School of Nanjing University,Department of General Surgery, Affiliated Drum Tower Hospital
[3] The Affiliated Drum Tower Hospital of Nanjing University Medical School,Department of Vascular Surgery
来源：
CELL DEATH & DISEASE | 2021年 / 12卷 / 12期
关键词：
D O I：
10.1038/s41419-021-04456-3
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页数：1
相关论文
共 4 条
  • [1] Tenascin-c knockdown suppresses vasculogenic mimicry of gastric cancer by inhibiting ERK- triggered EMT
    Kang, Xing
    Xu, En
    Wang, Xingzhou
    Qian, Lulu
    Yang, Zhi
    Yu, Heng
    Wang, Chao
    Ren, Chuanfu
    Wang, Yizhou
    Lu, Xiaofeng
    Xia, Xuefeng
    Guan, Wenxian
    Qiao, Tong
    CELL DEATH & DISEASE, 2021, 12 (10)
  • [2] Tenascin-c knockdown suppresses vasculogenic mimicry of gastric cancer by inhibiting ERK- triggered EMT
    Xing Kang
    En Xu
    Xingzhou Wang
    Lulu Qian
    Zhi Yang
    Heng Yu
    Chao Wang
    Chuanfu Ren
    Yizhou Wang
    Xiaofeng Lu
    Xuefeng Xia
    Wenxian Guan
    Tong Qiao
    Cell Death & Disease, 12
  • [3] Correction to: Tenascin-c knockdown suppresses vasculogenic mimicry of gastric cancer by inhibiting ERK- triggered EMT
    Xing Kang
    En Xu
    Xingzhou Wang
    Lulu Qian
    Zhi Yang
    Heng Yu
    Chao Wang
    Chuanfu Ren
    Yizhou Wang
    Xiaofeng Lu
    Xuefeng Xia
    Wenxian Guan
    Tong Qiao
    Cell Death & Disease, 12
  • [4] PD-L1 knockdown suppresses vasculogenic mimicry of non-small cell lung cancer by modulating ZEB1-triggered EMT
    Li, Wenjuan
    Wu, Jiatao
    Jia, Qianhao
    Shi, Yuqi
    Li, Fan
    Zhang, Linxiang
    Shi, Fan
    Wang, Xiaojing
    Wu, Shiwu
    BMC CANCER, 2024, 24 (01)
1